Table 4.
Cochrane review* | Year of publication | RMD | Type of intervention | Reported effect of intervention on fatigue† (reported quality of evidence) |
Physical exercise interventions | ||||
Cramp et al | 2013 | RA |
|
Small effect (M) |
Regnaux et al20 | 2019 | SpA |
|
No effect (VL) Reduction in fatigue (one study) (VL) |
Resistance exercise therapy | ||||
Busch et al | 2013 | FM |
|
Large effects (NR) |
FM |
|
No effect (NR) | ||
Whole body vibration (WBV) therapy | ||||
Bidonde et al | 2017 | FM |
|
Reduction that met the threshold for clinical relevance (VL) |
Meditative movement therapies therapy (MMT) (eg, Ai Chi, Tai Chi, Yoga awareness, Bat, Qi-Gong, Water yoga) | ||||
Theadom et al | 2015 | FM |
|
Advantageous (VL) |
Mixed exercise training (two or more components of physical exercise) | ||||
Bidonde et al | 2019 | FM |
|
More improvement postintervention, but at long-term follow-up only one-third studies showed an effect (M) |
FM |
|
No effect (VL) | ||
FM |
|
No effect (VL) | ||
FM |
|
No effect (VL) | ||
FM |
|
No effect (VL) | ||
Aerobics exercise (eg, cycling, walking, regardless of frequency, duration or intensity) | ||||
Bidonde et al | 2017 | FM |
|
No effect (one study) (VL) Significant effect (two studies) at long-term follow-up (VL) |
FM |
|
No effect (L) | ||
FM |
|
No effect (L) | ||
Busch et al | 2007 | FM |
|
No effect (VL) |
Aquatic exercise therapy | ||||
Bidonde et al | 2014 | FM |
|
No effect (NR) |
FM |
|
No effect (NR) | ||
FM |
|
No effect (NR) | ||
FM |
|
No effect (NR) | ||
Flexibility exercise therapy | ||||
Kim et al | 2019 | FM |
|
No effect (VL) |
Psychosocial interventions | ||||
Cramp et al | 2013 | RA |
|
Small effect (L) |
Mind and body therapy | ||||
Theadom et al | 2015 | FM |
|
No effect (VL) |
FM |
|
No effect (VL) | ||
Complementary interventions and complementary medicine | ||||
Cramp et al | 2013 | RA |
|
No effect (L) |
RA |
|
Greater mean reduction (L) | ||
Acupuncture | ||||
Deare et al | 2013 | FM |
|
Significant difference (L) |
FM |
|
No effect (M) | ||
FM |
|
No effect (NR) | ||
Transcutaneous electrical nerve stimulation (TENS) | ||||
Johnson et al | 2017 | FM |
|
Reduced fatigue with movement, but not at rest (VL) |
FM |
|
Clinically important improvements (VL) | ||
FM |
|
Clinically important improvements (VL) | ||
Lifestyle interventions | ||||
Cramp et al | 2013 | RA |
|
Improvement in intervention group‡ (L) |
RA |
|
Improvements between baseline and follow-up (L) | ||
RA |
|
Small improvements between baseline and follow-up (L) |
*Complete references are provided in online supplemental file S14–S17, as well as results of non-Cochrane systematic reviews and narrative reviews.
†Effect always refers to a reduction of fatigue compared to controls, unless otherwise indicated.
‡Between-arm comparisons were not reported.
FM, fibromyalgia; L, low; M, moderate; NR, not reported; RA, rheumatoid arthritis; RMDs, rheumatic and musculoskeletal diseases; SpA, spondyloarthritis; VL, very low.